Literature DB >> 8131807

Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease.

S Parha1, A Garoufi, P Yiallouros, C Theodoridis, T Karpathios.   

Abstract

We report on two patients whose clinical presentation resembled that of Kawasaki disease. The first patient was a boy with epilepsy, whose symptoms first appeared following treatment with carbamazepine. The second boy had Mediterranean Spotted Fever. The significance of medical history in avoiding overdiagnosis of Kawasaki disease is emphasized.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131807     DOI: 10.1007/bf01957233

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Kawasaki disease with atypical presentation.

Authors:  S Schuh; R M Laxer; J F Smallhorn; R I Hilliard; R D Rowe
Journal:  Pediatr Infect Dis J       Date:  1988-03       Impact factor: 2.129

2.  Centers for Disease Control (CDC) case definition for Kawasaki syndrome.

Authors:  A M Rauch; E S Hurwitz
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

Review 3.  What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada?

Authors:  A H Rowley; S T Shulman
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

4.  Kawasaki-like syndrome caused by carbamazepine.

Authors:  R A Hicks; J V Murphy; M A Jackson
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

Review 5.  The search for the etiology of Kawasaki disease.

Authors:  A H Rowley; S T Shulman
Journal:  Pediatr Infect Dis J       Date:  1987-06       Impact factor: 2.129

Review 6.  Kawasaki syndrome: review of new epidemiologic and laboratory developments.

Authors:  A M Rauch
Journal:  Pediatr Infect Dis J       Date:  1987-11       Impact factor: 2.129

7.  A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; Y Fujita; M Nagai; T Kawasaki; S Aso; Y Imada; I Shigematsu
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 9.  Kawasaki syndrome.

Authors:  R V Hicks; M E Melish
Journal:  Pediatr Clin North Am       Date:  1986-10       Impact factor: 3.278

10.  An atypical presentation of Kawasaki syndrome in an infant.

Authors:  A D Friedman
Journal:  Pediatr Dermatol       Date:  1988-05       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.